Vioxx redux - or how I learned to worry about industry-sponsored clinical trials
{{output}}
I read with interest Mark Wilson's recent article, "The New England Journal of Medicine: commercial conflict of interest and revisiting the Vioxx scandal". I believe this is an important contribution that underlines the aphorism "Those who don't know history a... ...
